Advisory Services Network’s Ligand Pharmaceuticals LGND Stock Holding History

Advisory Services Network’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.38K	Buy	+42	New	+$8.31K	﹤0.01%	3646
2025 Q4	–	Sell	-10	Closed	-$1.77K	–	3224
2025 Q3	$1.77K	Buy	+10	New	+$1.49K	﹤0.01%	3826
2024 Q1	–	Sell	-112	Closed	-$8K	–	2700
2023 Q4	$8K	Buy	+112	New	+$6.61K	﹤0.01%	2953
2023 Q2	–	Sell	-119	Closed	-$8.75K	–	2678
2023 Q1	$8.75K	Buy	119 +7	+6%	+$498	﹤0.01%	2933
2022 Q4	$7.48K	Buy	+112	New	+$7.28K	﹤0.01%	2965
2021 Q3	–	Sell	-180	Closed	-$15K	–	2446
2021 Q2	$15K	Buy	+180	New	+$15K	﹤0.01%	2625
2021 Q1	–	Sell	-260	Closed	-$16K	–	2250
2020 Q4	$16K	Sell	260 -3	-1%	-$171	﹤0.01%	2225
2020 Q3	$15K	Buy	+263	New	+$17.9K	﹤0.01%	2215
2020 Q2	–	Sell	-340	Closed	-$15K	–	2003
2020 Q1	$15K	Sell	340 -123	-27%	-$6.97K	﹤0.01%	2033
2019 Q4	$30K	Sell	463 -119	-20%	-$7.95K	﹤0.01%	1794
2019 Q3	$41K	Hold	582	–	–	﹤0.01%	1459
2019 Q2	$41K	Sell	582 -333	-36%	-$24.5K	﹤0.01%	1457
2019 Q1	$72K	Sell	915 -18	-2%	-$1.36K	0.01%	1103
2018 Q4	$79K	Buy	933 +11	+1%	+$1.17K	0.01%	983
2018 Q3	$158K	Sell	922 -37	-4%	-$5.58K	0.01%	824
2018 Q2	$139K	Sell	959 -3	-0.3%	-$335	0.01%	833
2018 Q1	$99K	Buy	962 +15	+2%	+$1.48K	0.01%	1022
2017 Q4	$81K	Buy	947 +721	+319%	+$62.5K	0.01%	1058
2017 Q3	$19K	Hold	226	–	–	﹤0.01%	1420
2017 Q2	$17K	Buy	226 +29	+15%	+$2.03K	﹤0.01%	1398
2017 Q1	$13K	Buy	+197	New	+$13K	﹤0.01%	1378
2016 Q3	$11K	Hold	180	–	–	﹤0.01%	1281
2016 Q2	$13K	Hold	180	–	–	﹤0.01%	1130
2016 Q1	$12K	Buy	+180	New	+$10.9K	﹤0.01%	1024

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Advisory Services Network's LGND Position: Q1 2026 in Review

Advisory Services Network opened a new position in Ligand Pharmaceuticals (LGND) in Q1 2026: 42 shares worth $8.38K. The stake represents ﹤0.01% of the portfolio and ranks #3646 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in LGND as recently as Q3 2025.

Advisory Services Network first reported a position in LGND in Q1 2016 and has held it in 24 quarters since. The position peaked at $158K in Q3 2018. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

Advisory Services Network held 42 shares of Ligand Pharmaceuticals worth $8.38K as of Q1 2026.
Ligand Pharmaceuticals was a new Advisory Services Network position in Q1 2026.
Ligand Pharmaceuticals made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #3646 holding.
Advisory Services Network first reported a position in Ligand Pharmaceuticals in Q1 2016 and has held it in 24 quarters since.
Advisory Services Network's Ligand Pharmaceuticals position peaked at $158K in Q3 2018.
357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.